Clinical trial Recruiting at 1 site Interventional Ages 19 and up

Preventing acute cholecystitis using endoscopic techniques

Official title: Efficacy of ETGBD Parallel Insertion With Fully Covered Self-expandable Metal Stent for Preventing Acute Cholecystitis in Patients With Low Cystic Duct Insertion

Run by Seoul National University Hospital · NCT06287112 · Data updated 2026-11-12

This study is testing if a new endoscopic technique can help prevent acute cholecystitis in patients with certain conditions better than standard care.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment35 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedJune 20, 2024
Main results expectedFebruary 20, 2027
Study endsMarch 30, 2027
Registry record updatedFebruary 20, 2025
Trial IDNCT06287112 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 19 and older with confirmed biliary obstruction and specific anatomical conditions.

Probably not a fit

Patients with prior gallbladder drainage procedures or those with acute cholecystitis will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the efficacy of endoscopic transpapillary gallbladder drainage (ETGBD) combined with the insertion of a fully covered self-expanding metal stent in preventing acute cholecystitis in patients with specific anatomical conditions. The study hypothesizes that this approach will reduce the frequency and severity of complications associated with biliary obstruction. Participants will be monitored for the occurrence of cholecystitis and the need for additional invasive procedures. The trial will compare outcomes in patients receiving this intervention against standard care.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of acute cholecystitis in at-risk patients.

How similar studies have gone: While similar approaches have been explored, this specific combination of ETGBD and fully covered stents is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults 19 years of age or older
2. Patients requiring endoscopic retrograde cholangiography and drainage for therapeutic purposes.
3. Patients with imaging (CT, Cholangiogram) confirmed confluence of the cystic duct with the distal third of the common bile duct.
4. Patients who have voluntary informed consent to participate in the study.

Exclusion Criteria:

* Patients who have undergone percutaneous/surgical bile duct or gallbladder drainage prior to study enrollment.
* Patients with anatomic deformity of the upper gastrointestinal tract after gastric or hepatobiliary surgery
* Patients with concomitant gastric/duodenal obstruction
* Patients with confirmed or suspected cystic duct obstruction on imaging studies
* Patients with acute cholecystitis, acute pancreatitis
* Patients who underwent cholecystectomy
* Patients with a life expectancy of less than 3 months
* Patients who are otherwise unable to undergo endoscopic retrograde cholangiopancreatography

Where it's running

  • Seoul National University Hospital
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.